Home About Us You are here Contact us History Many minds, better together. Our multidisciplinary team is keen to bring your valued molecule in the clinics. 2021 Ardena Group acquires Idifarma Idifarma, based in Pamplona, Spain, offers a full range of services spanning the pharma lifecycle from formulation, analytical to manufacturing services for highly potent drugs. Its capabilities include a platform for an accelerated path to clinic and innovating spray drying processes to overcome solubility issues. Established in 2001, Idifarma now has 120 employees. Read more 2020 GHO Capital becomes the new reference shareholder in Ardena GHO Capital acquires together with management the Ardena Group from Mentha Capital. GHO plans to further strengthen Ardena’s broad service proposition through organic and inorganic opportunities, adding to both the Company’s offering and international footprint. Read more 2018 Ardena Group acquires Syntagon Ardena acquires Scandinavian company Syntagon and strengthens its drug substance service offering. Drug substance batch sizes up to 100 kg can be produced. The 30-strong Syntagon team also adds specialist expertise in GMP chromatographic purification processes to our group. Read more 2018 Ardena Group acquires Chemconnection Ardena acquires Chemconnection, adding drug substance and nanomedicine expertise. Based at the Pivot Park life sciences campus in Oss, the Netherlands, ChemConnection employs a team of more than 60 with expertise in process and analytical development, cGMP manufacturing and stability studies for Drug Substances and nanomedicines. Its state-of-the-art facility has the capability to manufacture active ingredients up to 30 kg scale. Read more 2017 Ardena Group acquires ABL The acquisition of Netherlands based ABL broadens our preclinical and clinical offering to include bioanalytical and drug discovery services. The 60-strong ABL team specializes in the analysis of endogenous (biomarkers) and exogenous compounds (drugs) in biological matrices derived from humans and animals. ABL is active in all phases of drug development, including discovery, pre-clinical and clinical phases. Read More 2017 Launch of the Ardena brand Ardena is launched as the new brand for our services. The Ardena name reveals the increased service offering and complementary capabilities of the former companies, Pharmavize and Crystallics. Our logo resembles a compass and symbolizes Ardena’s navigational skills. During the drug development journey, we point, with minimized risk, our customers in the best direction. 2016 Acquisition of Crystallics Netherlands based Crystallics is the first company that joins Pharmavize in executing its vertical integration strategy. Crystallics is specialized in the identification, characterization and selection of the physical forms of drug substances. The company is a pioneer in the field of solid-state research and developed unique and proprietary technologies. Read more 2015 Mentha Capital invests in Pharmavize Pharmavize, a Belgium based CDMO specialized in drug and dossier development, engages private equity company Mentha Capital and starts executing a M&A strategy to become a leading, one-source and fully integrated contract developer of investigational drugs. Back to about us Executive Leadership Team Mission, vision & values Our approach History Contact us today Get in touch with us to discuss your next project Register for our newsletter Do you wish to remain up to date with drug development insights, industry trends & Ardena news? Click here to register Services Drug Substance Solid State Research Drug Product Clinical Logistics Bioanalysis Dossier Development Nanomedicine Navigation About Us Careers News & Insights Contact Legal entities General Terms and Conditions Contact details Ardena Kleimoer 4 B-9030 Mariakerke Belgium Telephone +32 9 267 65 00 Fax: +32 9 267 65 10 © Ardena Holding NV 2021 LinkedIn Sitemap Privacy Policy Ardena respects your right to privacy Your ability to make informed choices about the use of your information is important to us. This cookie statement details which cookies we or other parties can place on your device and how we and other parties use this information within Ardena. If you have any comments or questions about this cookie statement or the collection and use of your personal data, please contact our data protection GDPR@ardena.com More info. Set preferences Accept cookies